These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 840390)

  • 1. [Effect of D-penicillamine on hepatic gliopathy in tissue culture].
    Mossakowski MJ; Kraśnicka Z; Gajkowska B
    Neuropatol Pol; 1977; 15(1):57-74. PubMed ID: 840390
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomorphology of Wilsonian and hepatic gliopathy in vitro.
    Mossakowski MJ; Weinrauder H
    Neuropatol Pol; 1984; 22(2):161-78. PubMed ID: 6384819
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphology and histochemistry of Wilsonian and hepatogenic gliopathy in tissue culture.
    Mossakowski MJ; Renkawek K; Kraśnicka Z; Smialek M; Pronaszko A
    Acta Neuropathol; 1970; 16(1):1-16. PubMed ID: 4247952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sera from patients with hepatolenticular degeneration treated with D-penicillamine on the development of Wilsonian gliopathy in vitro].
    Weinrauder H; Mossakowski MJ; Ganuszkina IV
    Neuropatol Pol; 1986; 24(2):169-81. PubMed ID: 3785687
    [No Abstract]   [Full Text] [Related]  

  • 5. [Natural history of Opalski's cells].
    Mossakowski MJ; Weinrauder H
    Neuropatol Pol; 1984; 22(4):471-81. PubMed ID: 6533473
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental studies on the pathogenesis of hepatogenic encephalopathy.
    Mossakowski MJ
    Riv Patol Nerv Ment; 1978; 99(1):25-36. PubMed ID: 752896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of Opalski's cells as a contribution to the understanding of the pathogenesis of lesions of the central nervous system in hepato-cerebral diseases].
    Mossakowski MJ; Kraśnicka Z; Renkawek K
    Neuropatol Pol; 1972; 10(3):385-94. PubMed ID: 5078162
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolytic activity in patients with hepatolenticular degeneration: the effect of penicillamine].
    Babić T; Relja M
    Lijec Vjesn; 1988 Dec; 110(12):420-2. PubMed ID: 3246941
    [No Abstract]   [Full Text] [Related]  

  • 9. [2 cases of Wilson's disease diagnosed at the infra-clinical stage. Prolonged, early treatment using penicillamine. Result].
    Hamza B; el-Kamel M
    Tunis Med; 1974; 52(1):29-31. PubMed ID: 4215182
    [No Abstract]   [Full Text] [Related]  

  • 10. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
    McQuaid A; Lamand M; Mason J
    J Lab Clin Med; 1992 Jun; 119(6):744-50. PubMed ID: 1593220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
    Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
    Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism and pharmacology of D-penicillamine in man.
    Perrett D
    J Rheumatol Suppl; 1981; 7():41-50. PubMed ID: 7014876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement dysfunction and hepatic encephalopathy.
    Layrargues GP
    Metab Brain Dis; 2001 Jun; 16(1-2):27-35. PubMed ID: 11726085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-penicillamine.
    Singh S; Kohli V
    Indian Pediatr; 1991 Jul; 28(7):779-85. PubMed ID: 1800352
    [No Abstract]   [Full Text] [Related]  

  • 15. Methods for assaying D-penicillamine in a clinical setting.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):31-4. PubMed ID: 6723121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of the hepatolenticular degeneration and results of its continuous therapy].
    Brailski C; Kolarski V; Krastev I
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):35-42. PubMed ID: 5501424
    [No Abstract]   [Full Text] [Related]  

  • 17. Penicillamine as antioxidant.
    Miki M
    Methods Enzymol; 1994; 234():542-7. PubMed ID: 7808330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Wilson's disease. Etiopathogenetic, morphologic, clinical and therapeutic considerations, Case report].
    Mancosu M; Bottino D; Previati G; Pighini A; Valli F; Colombo B
    Minerva Pediatr; 1972 Mar; 24(11):419-33. PubMed ID: 5019260
    [No Abstract]   [Full Text] [Related]  

  • 19. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 20. [D(-)penicillamine: pharmacology and clinical uses].
    Gattoni A; De Donato MT; Catalano G; Astarita C; Bernabò R; Altucci P
    Clin Ter; 1982 Nov; 103(4):411-44. PubMed ID: 6217944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.